News of Note—Merck, FluGen and more

In this week's news of note, Merck posted a Gardasil sales increase. (NS Newsflash/CC BY 2.0)

Here is some other vaccine news of note for the week.

> Merck's Gardasil sales grew 24% in the first quarter to $660 million. Release

> FluGen's CEO said the company will consider seeking funding from a new Gates Foundation universal flu vaccine challenge. Xconomy article

> Rational Vaccines, a company that has come under fire for unregulated vaccine testing, removed a lawsuit to federal court in Illinois. Law360 article

> Pfizer's Prevnar sales slipped 1% to $1.38 billion in the first quarter. Release (PDF)